Ya-Ling Han (Yaling Han)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Atrial Fibrillation

Vascular Smooth Muscle Cells

Top Venues

BioMed research international

Cell death & disease

Cardiology research and practice

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaoli Cheng, Dan Liu, Ruinan Xing, Haixu Song, Xiaoxiang Tian, Chenghui Yan, Ya-Ling Han
Corrigendum to "Orosomucoid 1 Attenuates Doxorubicin-Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Nrf2 Signaling". BioMed research international 2022 (2022)
Dan Liu, Xiaoxiang Tian, Yanxia Liu, Haixu Song, Xiaoli Cheng, Xiaolin Zhang, Cheng-Hui Yan, Ya-Ling Han
CREG ameliorates the phenotypic switching of cardiac fibroblasts after myocardial infarction via modulation of CDC42. Cell death & disease 12 (4) (2021)
Xiaoli Cheng, Dan Liu, Ruinan Xing, Haixu Song, Xiaoxiang Tian, Chenghui Yan, Ya-Ling Han
Orosomucoid 1 Attenuates Doxorubicin-Induced Oxidative Stress and Apoptosis in Cardiomyocytes via Nrf2 Signaling. BioMed research international 2020 (2020)
Zhi-Wei Hou, Hai-Bo Yu, Yan-Chun Liang, Yang Gao, Guo-Qing Xu, Min Wu, Zhu Mei, Zu-Lu Wang, Zhi-Guo Li, Yu-Ying Li, Hai-Xu Song, Jia-Yin Li, Ya-Ling Han
Circulating Soluble ST2 Predicts All-Cause Mortality in Severe Heart Failure Patients with an Implantable Cardioverter Defibrillator. Cardiology research and practice 2020 (2020)
Yujie Zhang, Xiaolin Zhang, Xi Zhang, Yi Cai, Minghui Cheng, Chenghui Yan, Ya-Ling Han
Molecular Targets and Pathways Contributing to the Effects of Wenxin Keli on Atrial Fibrillation Based on a Network Pharmacology Approach. Evidence-based complementary and alternative medicine : eCAM 2020 (2020)